Updates are available Correction dated 2019-09-09
Click to view Correction: https://doi.org/10.1038/s41467-019-12060-5
-
Authors
Chen, Huimei
Moreno-Moral, Aida https://orcid.org/0000-0002-8155-3146
Pesce, Francesco
Devapragash, Nithya
Mancini, Massimiliano
Heng, Ee Ling
Rotival, Maxime
Srivastava, Prashant K.
Harmston, Nathan
Shkura, Kirill
Rackham, Owen J. L.
Yu, Wei-Ping
Sun, Xi-Ming
Tee, Nicole Gui Zhen
Tan, Elisabeth Li Sa
Barton, Paul J. R. https://orcid.org/0000-0002-1165-7767
Felkin, Leanne E.
Lara-Pezzi, Enrique
Angelini, Gianni
Beltrami, Cristina
Pravenec, Michal
Schafer, Sebastian https://orcid.org/0000-0002-6909-8275
Bottolo, Leonardo https://orcid.org/0000-0002-6381-2327
Hubner, Norbert
Emanueli, Costanza
Cook, Stuart A. https://orcid.org/0000-0001-6628-194X
Petretto, Enrico https://orcid.org/0000-0003-2163-5921
-
Funding
Funding for this research was provided by:
MOH | National Medical Research Council (CBRG/0106/2016)
British Heart Foundation (FS/11/25/28740)
- License Information
-
More Information
Article History
Received: 10 October 2018
Accepted: 19 July 2019
First Online: 9 August 2019
Change Date: 9 September 2019
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing interests
: E.P. and A.M.-M. have filed a patent (application number 1908544.8; status: “provisional application”; date 14 June 2019) concerning the treatment and/or prevention of disease through inhibition of the pro-fibrotic functions of WWP2. The remaining authors declare no competing interests.
